Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Goodwill (2023 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Goodwill data on record, last reported at $2.0 million in Q4 2025.

  • For Q4 2025, Goodwill changed N/A year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, changed N/A, while the annual FY2025 figure was $2.0 million, N/A changed from the prior year.
  • Goodwill reached $2.0 million in Q4 2025 per INDV's latest filing, roughly flat from $2.0 million in the prior quarter.
  • Across five years, Goodwill topped out at $2.0 million in Q1 2024 and bottomed at $2.0 million in Q1 2024.